Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4464414
Max Phase: Preclinical
Molecular Formula: C33H40F3N7O10S
Molecular Weight: 669.76
Molecule Type: Unknown
Associated Items:
ID: ALA4464414
Max Phase: Preclinical
Molecular Formula: C33H40F3N7O10S
Molecular Weight: 669.76
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc(OC)c(C(=O)Nc2c[nH]nc2C(=O)NC2CCN(S(=O)(=O)c3cccc(NC(=O)/C=C/CN(C)C)c3)CC2)c(OC)c1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C31H39N7O8S.C2HF3O2/c1-37(2)13-7-10-27(39)33-21-8-6-9-23(16-21)47(42,43)38-14-11-20(12-15-38)34-31(41)29-24(19-32-36-29)35-30(40)28-25(45-4)17-22(44-3)18-26(28)46-5;3-2(4,5)1(6)7/h6-10,16-20H,11-15H2,1-5H3,(H,32,36)(H,33,39)(H,34,41)(H,35,40);(H,6,7)/b10-7+;
Standard InChI Key: BJPZBZHYCSNPHD-HCUGZAAXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 669.76 | Molecular Weight (Monoisotopic): 669.2581 | AlogP: 2.33 | #Rotatable Bonds: 13 |
Polar Surface Area: 184.29 | Molecular Species: BASE | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.74 | CX Basic pKa: 8.80 | CX LogP: 1.58 | CX LogD: 0.26 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.20 | Np Likeness Score: -1.41 |
1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024] |
Source(1):